Next-generation protein drugs

Nature Biotechnology

Volumn 22, Issue 5, 2004, Pages 521-522

  Tomlinson, Ian M ^a  

^a Domantis Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; APROTININ; CETUXIMAB; DOMAIN ANTIBODY; INFLIXIMAB; INSULIN; LECTIN; LIPOCALIN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GROWTH HORMONE; RECOMBINANT PROTEIN; RITUXIMAB; TRANSFERRIN; TRINECTIN DERIVATIVE; UNCLASSIFIED DRUG; VACCINE;

BINDING AFFINITY; BIOPHYSICS; DRUG DESIGN; DRUG RESEARCH; DRUG SAFETY; DRUG SOLUBILITY; DRUG SPECIFICITY; DRUG STABILITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SHORT SURVEY; STRUCTURE ANALYSIS;

ANKYRIN REPEAT; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; PROTEIN CONFORMATION; PROTEINS;

EID: 2342529063     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0504-521     Document Type: Short Survey

References (7)

1. Reichert, J.M. Nat. Biotechnol. 19, 819-822 (2001).
2. Binz, H.K. et al. Nat. Biotechnol. 22, 575-582 (2004).
3. Scott, J.K. & Smith, G.P. Science 249, 386-390 (1990).
4. Mattheakis, L.C., Bhatt, R.R. & Dower W.J. Proc. Natl. Acad. Sci. USA 91, 9022-9026 (1994).
5. Ali, S.A., Joao, H.C., Hammerschmid, F., Eder, J. & Steinkasserer, A. J. Biol. Chem. 274, 24066-24073 (1999).
6. Jespers, L., Schon, O., James, L.C., Veprintsev, D. & Winter, G. J. Mol. Biol. 337, 893-903 (2004).
7. Sedgwick, S.G. & Smerdon, S.J. Trends Biochem. Sci. 24, 311-316 (1999).